The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

Stopped early · Not applicable

Conditions studied: Cervical Prostaglandin EP3 Receptors, Pregnancy

In brief

The purpose of this study is to determine the effect of mifepristone on the expression of three cervical EP3 receptor isoforms (EP3-2, EP3-3 and EP3-6) in pregnant women ≤63 days gestational age.

Key facts

Study ID

NCT01224509

Run by

University of Southern California

People needed

18

Starts

2004-09-01

Expected to finish

2005-03-01

Last updated by the study team

2010-10-20

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• good general health
• ≥18 years old
• seeking termination of a viable intrauterine pregnancy of ≤63 days, without any evidence of a threatened or spontaneous abortion

You may not qualify if…

• medical problems
• confirmed or suspected ectopic pregnancy
• having taken medications in the seven days prior to enrollment that would affect PG synthesis or metabolism of mifepristone

Where it is running

• Women's and Children's Hospital, Reproductive Research Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.